2018 and Beyond: Bulgaria Pharmaceutical and Healthcare Market Trends and Outlook Study to 2025
Spending on medicines and healthcare in Bulgaria witnessed steady growth in 2017, reflecting strong potential for new medicine development, infrastructure building and new entry/ expansion opportunities. Both Pharmaceutical sales and consumption are on rise and the outlook to 2025 remains robust driven by strong pharmaceutical market fundamentals.
The goal of this report is to provide complete strategic analysis and forecast the pharmaceutical industry segments over the near to long term future.
This report focuses its attention on pharmaceutical market in Bulgaria and presents market trends, drivers and challenges facing the R&D professionals, investors, manufacturers, strategists, regulatory and other players. It also presents the pharmaceutical sales of prescription medicines and generic drugs. Further, pharmaceutical imports and exports data is also provided for the country.
The research study on Bulgaria healthcare spending provides outlook of total spending, government expenditure, private expenditure to 2025. Further, the level of out-of-pocket costs borne by patients is also analyzed.
It additionally explores the level and growth of expenditure on healthcare, new drugs and ongoing research studies. The report also considers the Bulgaria healthcare industry prospects and infrastructure detailing hospitals, physicians, bed count, and other facilities. The report also analyzes the disease epidemiology trends through details of leading causes of death.
Through transparent and consistent methodology, the research work provides meaningful evidence based insights into the industry. Further, objective measures are presented in ready to use format, which enables ease of understanding of Bulgaria pharmaceutical market insights and outlook.
The goal of this report is to provide complete strategic analysis and forecast the pharmaceutical industry segments over the near to long term future.
This report focuses its attention on pharmaceutical market in Bulgaria and presents market trends, drivers and challenges facing the R&D professionals, investors, manufacturers, strategists, regulatory and other players. It also presents the pharmaceutical sales of prescription medicines and generic drugs. Further, pharmaceutical imports and exports data is also provided for the country.
The research study on Bulgaria healthcare spending provides outlook of total spending, government expenditure, private expenditure to 2025. Further, the level of out-of-pocket costs borne by patients is also analyzed.
It additionally explores the level and growth of expenditure on healthcare, new drugs and ongoing research studies. The report also considers the Bulgaria healthcare industry prospects and infrastructure detailing hospitals, physicians, bed count, and other facilities. The report also analyzes the disease epidemiology trends through details of leading causes of death.
Through transparent and consistent methodology, the research work provides meaningful evidence based insights into the industry. Further, objective measures are presented in ready to use format, which enables ease of understanding of Bulgaria pharmaceutical market insights and outlook.
1 TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 EXECUTIVE SUMMARY
2.1 Bulgaria Pharmaceutical and Healthcare Industry Snapshot
2.2 Bulgaria Pharmaceuticals Market Overview
3 BULGARIA PHARMACEUTICAL MARKET STRATEGIC ANALYSIS REVIEW
3.1 Pharmaceutical Trends in Bulgaria
3.2 Drivers and Restraints
3.2.1 Market Drivers in Bulgaria Pharmaceuticals and Healthcare Industry
3.2.2 Drivers Explained
3.2.3 Market Restraints in Bulgaria Pharmaceuticals and Healthcare Industry
3.2.4 Restraints Explained
4 BULGARIA PHARMACEUTICAL MARKET OUTLOOK
4.1 Bulgaria Pharmaceutical Sales, $ Million, 2015- 2025
4.2 Bulgaria Pharmaceutical Exports, $ million, 2015- 2025
4.3 Bulgaria Pharmaceutical Imports, $ Million, 2015- 2025
4.4 Bulgaria (% contribution) to Regional Pharmaceutical Market size, 2017
4.5 Bulgaria (% contribution) to Global Pharmaceutical Market size, 2017
4.6 Bulgaria Prescription Drug Sales, $ Million, 2015- 2025
4.7 Bulgaria Generic Drug Sales, $ Million, 2015- 2025
5 BULGARIA HEALTHCARE MARKET OUTLOOK
5.1 Bulgaria Healthcare Expenditure Outlook, 2015- 2025
5.2 Bulgaria Healthcare Expenditure (% of GDP), 2015- 2025
5.3 Bulgaria Government Healthcare Expenditure (% of total expenditure), 2015- 2025
5.4 Bulgaria Private Healthcare Expenditure (% of total expenditure), 2015- 2025
5.5 Out of pocket expenditure (% of total expenditure) in Bulgaria, 2015- 2025
6 BULGARIA HEALTHCARE MARKET STATISTICS
6.1 Bulgaria Mortality by Disease Category, 2017
6.2 Number of Hospitals in Bulgaria, 2007- 2017
6.3 Number of Hospital Beds in Bulgaria, 2007- 2017
6.4 Physicians Count in Bulgaria, 2007- 2017
6.5 Pharmacists Count in Bulgaria, 2007- 2017
7 BULGARIA CLINICAL TRIALS RESEARCH INDUSTRY
7.1 Total Ongoing Clinical Trials in Bulgaria, 2017
7.2 Ongoing Clinical Trials by Disease Category in Bulgaria, 2017
7.3 Ongoing Clinical Trials by Type, 2017
7.4 Ongoing Clinical Trials by Status, 2017
7.5 Ongoing Clinical Trials by Sponsor Type, 2017
8 BULGARIA DEMOGRAPHIC AND MACROECONOMIC PROFILE
8.1 Bulgaria Population Forecast by Age Group, 2005- 2025
8.2 Bulgaria Population Forecast by Location, 2005- 2025
8.3 Bulgaria GDP Forecast, 2005- 2025
8.4 Bulgaria GDP Per Capita Forecast, 2005- 2025
8.5 Bulgaria Disposable Income Forecast, 2005- 2025
9 BUSINESS PROFILES OF LEADING PHARMACEUTICAL COMPANIES
9.1 Johnson and Johnson Pharmaceutical Company Profile
9.2 Bayer Pharmaceutical Company Profile
9.3 Novartis Pharmaceutical Company Profile
9.4 Pfizer Pharmaceutical Company Profile
9.5 Roche Pharmaceutical Company Profile
9.6 Sanofi Pharmaceutical Company Profile
9.7 Merck Pharmaceutical Company Profile
9.8 Gilead Sciences Pharmaceutical Company Profile
9.9 GlaxoSmithKline Pharmaceutical Company Profile
9.10. AstraZeneca Pharmaceutical Company Profile
10 RECENT INDUSTRY DEVELOPMENTS IN BULGARIA PHARMACEUTICALS AND HEALTHCARE MARKETS
11 APPENDIX
11.1 About VPA Research
11.2 Sources and Methodology
1.1 List of Tables
1.2 List of Figures
2 EXECUTIVE SUMMARY
2.1 Bulgaria Pharmaceutical and Healthcare Industry Snapshot
2.2 Bulgaria Pharmaceuticals Market Overview
3 BULGARIA PHARMACEUTICAL MARKET STRATEGIC ANALYSIS REVIEW
3.1 Pharmaceutical Trends in Bulgaria
3.2 Drivers and Restraints
3.2.1 Market Drivers in Bulgaria Pharmaceuticals and Healthcare Industry
3.2.2 Drivers Explained
3.2.3 Market Restraints in Bulgaria Pharmaceuticals and Healthcare Industry
3.2.4 Restraints Explained
4 BULGARIA PHARMACEUTICAL MARKET OUTLOOK
4.1 Bulgaria Pharmaceutical Sales, $ Million, 2015- 2025
4.2 Bulgaria Pharmaceutical Exports, $ million, 2015- 2025
4.3 Bulgaria Pharmaceutical Imports, $ Million, 2015- 2025
4.4 Bulgaria (% contribution) to Regional Pharmaceutical Market size, 2017
4.5 Bulgaria (% contribution) to Global Pharmaceutical Market size, 2017
4.6 Bulgaria Prescription Drug Sales, $ Million, 2015- 2025
4.7 Bulgaria Generic Drug Sales, $ Million, 2015- 2025
5 BULGARIA HEALTHCARE MARKET OUTLOOK
5.1 Bulgaria Healthcare Expenditure Outlook, 2015- 2025
5.2 Bulgaria Healthcare Expenditure (% of GDP), 2015- 2025
5.3 Bulgaria Government Healthcare Expenditure (% of total expenditure), 2015- 2025
5.4 Bulgaria Private Healthcare Expenditure (% of total expenditure), 2015- 2025
5.5 Out of pocket expenditure (% of total expenditure) in Bulgaria, 2015- 2025
6 BULGARIA HEALTHCARE MARKET STATISTICS
6.1 Bulgaria Mortality by Disease Category, 2017
6.2 Number of Hospitals in Bulgaria, 2007- 2017
6.3 Number of Hospital Beds in Bulgaria, 2007- 2017
6.4 Physicians Count in Bulgaria, 2007- 2017
6.5 Pharmacists Count in Bulgaria, 2007- 2017
7 BULGARIA CLINICAL TRIALS RESEARCH INDUSTRY
7.1 Total Ongoing Clinical Trials in Bulgaria, 2017
7.2 Ongoing Clinical Trials by Disease Category in Bulgaria, 2017
7.3 Ongoing Clinical Trials by Type, 2017
7.4 Ongoing Clinical Trials by Status, 2017
7.5 Ongoing Clinical Trials by Sponsor Type, 2017
8 BULGARIA DEMOGRAPHIC AND MACROECONOMIC PROFILE
8.1 Bulgaria Population Forecast by Age Group, 2005- 2025
8.2 Bulgaria Population Forecast by Location, 2005- 2025
8.3 Bulgaria GDP Forecast, 2005- 2025
8.4 Bulgaria GDP Per Capita Forecast, 2005- 2025
8.5 Bulgaria Disposable Income Forecast, 2005- 2025
9 BUSINESS PROFILES OF LEADING PHARMACEUTICAL COMPANIES
9.1 Johnson and Johnson Pharmaceutical Company Profile
9.2 Bayer Pharmaceutical Company Profile
9.3 Novartis Pharmaceutical Company Profile
9.4 Pfizer Pharmaceutical Company Profile
9.5 Roche Pharmaceutical Company Profile
9.6 Sanofi Pharmaceutical Company Profile
9.7 Merck Pharmaceutical Company Profile
9.8 Gilead Sciences Pharmaceutical Company Profile
9.9 GlaxoSmithKline Pharmaceutical Company Profile
9.10. AstraZeneca Pharmaceutical Company Profile
10 RECENT INDUSTRY DEVELOPMENTS IN BULGARIA PHARMACEUTICALS AND HEALTHCARE MARKETS
11 APPENDIX
11.1 About VPA Research
11.2 Sources and Methodology
